181 related articles for article (PubMed ID: 10664991)
1. Recent developments in 99Tcm-labelled peptide-based radiopharmaceuticals: an overview.
Okarvi SM
Nucl Med Commun; 1999 Dec; 20(12):1093-112. PubMed ID: 10664991
[TBL] [Abstract][Full Text] [Related]
2. Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases.
Okarvi SM
Med Res Rev; 2004 May; 24(3):357-97. PubMed ID: 14994368
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in fluorine-18 labelled peptide radiopharmaceuticals.
Okarvi SM
Eur J Nucl Med; 2001 Jul; 28(7):929-38. PubMed ID: 11504093
[TBL] [Abstract][Full Text] [Related]
4. Peptide radiopharmaceuticals for diagnosis and therapy.
Signore A; Annovazzi A; Chianelli M; Corsetti F; Van de Wiele C; Watherhouse RN
Eur J Nucl Med; 2001 Oct; 28(10):1555-65. PubMed ID: 11685500
[TBL] [Abstract][Full Text] [Related]
5. Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.
Sosabowsky J; Melendez-Alafort L; Mather S
Q J Nucl Med; 2003 Dec; 47(4):223-37. PubMed ID: 14973415
[TBL] [Abstract][Full Text] [Related]
6. Small peptides radiolabeled with 99mTc.
Lister-James J; Moyer BR; Dean T
Q J Nucl Med; 1996 Sep; 40(3):221-33. PubMed ID: 8961801
[TBL] [Abstract][Full Text] [Related]
7. Radiopharmaceuticals: new antimicrobial agents.
Lupetti A; Nibbering PH; Welling MM; Pauwels EK
Trends Biotechnol; 2003 Feb; 21(2):70-3. PubMed ID: 12573855
[TBL] [Abstract][Full Text] [Related]
8. A receptor-specific peptide for imaging infection and inflammation.
Rao PS; Pallela VR; Vassileva-Belnikolovska D; Jungkind D; Thakur ML
Nucl Med Commun; 2000 Nov; 21(11):1063-70. PubMed ID: 11192713
[TBL] [Abstract][Full Text] [Related]
9. (99m)Tc-radiolabelled peptides for tumour imaging: present and future.
Bolzati C; Refosco F; Marchiani A; Ruzza P
Curr Med Chem; 2010; 17(24):2656-83. PubMed ID: 20491630
[TBL] [Abstract][Full Text] [Related]
10. Labelled Stealth liposomes in experimental infection: an alternative to leukocyte scintigraphy?
Oyen WJ; Boerman OC; Storm G; van Bloois L; Koenders EB; Crommelin DJ; van der Meer JW; Corstens FH
Nucl Med Commun; 1996 Sep; 17(9):742-8. PubMed ID: 8895901
[TBL] [Abstract][Full Text] [Related]
11. Different chelators and different peptides together influence the in vitro and mouse in vivo properties of 99Tcm.
Qu T; Wang Y; Zhu Z; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 2001 Feb; 22(2):203-15. PubMed ID: 11258408
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and radiation dosimetry of 99Tcm-labelled monoclonal antibody B43.13 in ovarian cancer patients.
McQuarrie SA; Baum RP; Niesen A; Madiyalakan R; Korz W; Sykes TR; Sykes CJ; Hör G; McEwan AJ; Noujaim AA
Nucl Med Commun; 1997 Sep; 18(9):878-86. PubMed ID: 9352556
[TBL] [Abstract][Full Text] [Related]
13. Hybridization of a 99Tcm-labelled oligodeoxynucleotide to CAPL RNA.
Hjelstuen OK; Maelandsmo GM; Tønnesen HH; Bremmer PO; Verbruggen AM
Nucl Med Commun; 1998 Aug; 19(8):803-12. PubMed ID: 9751936
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeled peptides in diagnosis and therapy.
Weiner RE; Thakur ML
Semin Nucl Med; 2001 Oct; 31(4):296-311. PubMed ID: 11710772
[TBL] [Abstract][Full Text] [Related]
15. Non-oncologic applications of radiolabeled peptides in nuclear medicine.
Knight LC
Q J Nucl Med; 2003 Dec; 47(4):279-91. PubMed ID: 14973420
[TBL] [Abstract][Full Text] [Related]
16. Structural modifications of ⁹⁹mTc-labelled bombesin-like peptides for optimizing pharmacokinetics in prostate tumor targeting.
Liolios CC; Fragogeorgi EA; Zikos C; Loudos G; Xanthopoulos S; Bouziotis P; Paravatou-Petsotas M; Livaniou E; Varvarigou AD; Sivolapenko GB
Int J Pharm; 2012 Jul; 430(1-2):1-17. PubMed ID: 22459664
[TBL] [Abstract][Full Text] [Related]
17. 99Tcm-p-aminohippuric acid as a new renal agent.
Djokić D; Janković D; Maksin T; Jaksić E; Beatović S; Han R
Nucl Med Commun; 1999 Dec; 20(12):1133-40. PubMed ID: 10664994
[TBL] [Abstract][Full Text] [Related]
18. An in vitro model for the scintigraphic detection of thrombi using a 99Tcm-labelled antifibrin monoclonal antibody.
Wasser MN; Cleyndert P; Camps JA; Feitsma RI; Nieuwenhuizen W; Pauwels EK
Nucl Med Commun; 1989 Sep; 10(9):653-9. PubMed ID: 2616104
[TBL] [Abstract][Full Text] [Related]
19. Radiolabelled peptides: now and the future.
Thakur ML
Nucl Med Commun; 1995 Sep; 16(9):724-32. PubMed ID: 7478404
[TBL] [Abstract][Full Text] [Related]
20. Immunoscintigraphy of tumours using 99Tcm-labelled monoclonal antibodies: a review.
Reilly RM
Nucl Med Commun; 1993 May; 14(5):347-59. PubMed ID: 8510874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
